Findlay DM - Search Results

1

The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.

Pan B, To LB, Farrugia AN, Findlay DM, Green J, Gronthos S, Evdokiou A, Lynch K, Atkins GJ, Zannettino AC. Pan B, et al. Among authors: findlay dm. Bone. 2004 Jan;34(1):112-23. doi: 10.1016/j.bone.2003.08.013. Bone. 2004. PMID: 14751568

2

RANKL expression is related to the differentiation state of human osteoblasts.

Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC. Atkins GJ, et al. Among authors: findlay dm. J Bone Miner Res. 2003 Jun;18(6):1088-98. doi: 10.1359/jbmr.2003.18.6.1088. J Bone Miner Res. 2003. PMID: 12817763 Free article.

3

The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).

Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, Zannettino AC. Pan B, et al. Among authors: findlay dm. J Bone Miner Res. 2004 Jan;19(1):147-54. doi: 10.1359/jbmr.2004.19.1.147. J Bone Miner Res. 2004. PMID: 14753746 Free article.

4

Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients.

Tsangari H, Findlay DM, Zannettino AC, Pan B, Kuliwaba JS, Fazzalari NL. Tsangari H, et al. Among authors: findlay dm. Bone. 2006 Dec;39(6):1226-35. doi: 10.1016/j.bone.2006.06.019. Epub 2006 Aug 22. Bone. 2006. PMID: 16926124

5

RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone.

Atkins GJ, Kostakis P, Vincent C, Farrugia AN, Houchins JP, Findlay DM, Evdokiou A, Zannettino AC. Atkins GJ, et al. Among authors: findlay dm. J Bone Miner Res. 2006 Sep;21(9):1339-49. doi: 10.1359/jbmr.060604. J Bone Miner Res. 2006. PMID: 16939392 Free article.

6

Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.

Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, O'Loughlin PD, Morris HA. Atkins GJ, et al. Among authors: findlay dm. Bone. 2007 Jun;40(6):1517-28. doi: 10.1016/j.bone.2007.02.024. Epub 2007 Mar 2. Bone. 2007. PMID: 17395559

7

Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells.

Kitahama S, Gibson MA, Hatzinikolas G, Hay S, Kuliwaba JL, Evdokiou A, Atkins GJ, Findlay DM. Kitahama S, et al. Among authors: findlay dm. Bone. 2000 Jul;27(1):61-7. doi: 10.1016/s8756-3282(00)00292-1. Bone. 2000. PMID: 10865210

8

Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.

Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM. Atkins GJ, et al. Among authors: findlay dm. Bone. 2001 Apr;28(4):370-7. doi: 10.1016/s8756-3282(01)00404-5. Bone. 2001. PMID: 11336917

9

Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis.

Evdokiou A, Labrinidis A, Bouralexis S, Hay S, Findlay DM. Evdokiou A, et al. Among authors: findlay dm. Bone. 2003 Aug;33(2):216-28. doi: 10.1016/s8756-3282(03)00223-0. Bone. 2003. PMID: 14499355

10

Receptor activator of nuclear factor-kappaB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo.

Farrugia AN, Atkins GJ, To LB, Pan B, Horvath N, Kostakis P, Findlay DM, Bardy P, Zannettino AC. Farrugia AN, et al. Among authors: findlay dm. Cancer Res. 2003 Sep 1;63(17):5438-45. Cancer Res. 2003. PMID: 14500379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters